July 17, 2014
July 17, 2014
Enteris BioPharma Oral Peptide Delivery Technology Enables Key Clinical Milestone for Acute and Chronic Pain Drug Cara Therapeutics Initiates Further Phase 1a/1b Trial of Enteris’ Tablet […]
January 10, 2014
January 10, 2014
Enteris BioPharma to Present at Biotech Showcase™ 2014 Boonton, NJ – January 9, 2014 – Enteris BioPharma, Inc., an industry leader in innovative oral dosage […]
December 3, 2013
December 3, 2013
Enteris BioPharma Forms Scientific Advisory Board to Enhance Leadership in Oral Delivery of Peptide and Small Molecule Drugs Esteemed Scientific and Thought Leaders – Steven J. […]
September 30, 2013
September 30, 2013
Enteris BioPharma and Nordic BioScience’s KeyBioScience Enter Strategic Licensing Agreement to Develop Metabolic Peptides Using Enteris’ Proprietary Oral Drug Delivery and Manufacturing Platform Companies to Partner […]
August 22, 2013
August 22, 2013
Enteris BioPharma Appoints Timothy J. Saxon, Vice President of Business Development, to Expand “Peptelligence® Partnering” Program Enteris Seeks to Enhance Current Feasibility-to-Licensing Strategy with Partnerships Targeting […]
KNOWLEDGE CENTER
Expand your knowledge. The Enteris BioPharma Knowledge Center is a library of educational tools.
LEARN MOREKNOWLEDGE CENTER
Expand your knowledge. The Enteris BioPharma Knowledge Center is a library of educational tools.
LEARN MORE
